These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3563266)

  • 41. [Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment].
    González-Juanatey JR; Amaro Cendón A; Vega Fernández M; Gil de la Peña M
    Med Clin (Barc); 1988 Jan; 90(3):93-6. PubMed ID: 3280894
    [No Abstract]   [Full Text] [Related]  

  • 42. Vasodilators in heart failure secondary to coronary artery disease.
    Parmley WW; Rouleau JL; Chatterjee K
    Am Heart J; 1982 Apr; 103(4 Pt 2):625-32. PubMed ID: 7064804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasodilator therapy for chronic heart failure.
    Chatterjee K; Parmley WW
    Annu Rev Pharmacol Toxicol; 1980; 20():475-512. PubMed ID: 6770743
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC; Robinson PH
    Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986
    [No Abstract]   [Full Text] [Related]  

  • 45. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure.
    Chatterjee K; Rouleau JL
    Acta Med Scand Suppl; 1981; 651():295-303. PubMed ID: 7034478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant therapy of chronic refractory cardiac failure with oral hydralazine and isosorbide dinitrate.
    Kothiala A; Ramnani K; Patel HR; Mehta NC; Shah CP
    J Assoc Physicians India; 1983 Jun; 31(6):343-6. PubMed ID: 6654793
    [No Abstract]   [Full Text] [Related]  

  • 48. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Eisenberger AB
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15761995
    [No Abstract]   [Full Text] [Related]  

  • 49. Vasodilator therapy in congestive heart failure.
    N Engl J Med; 1986 Nov; 315(19):1227-8. PubMed ID: 3762645
    [No Abstract]   [Full Text] [Related]  

  • 50. Question: does isosorbide dinitrate/hydralazine therapy benefit systolic heart failure patients with renal insufficiency?
    Pan L; Payne J; Clark M
    J Okla State Med Assoc; 2011 Feb; 104(2):49-50. PubMed ID: 21815321
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of the effects of dopamine, hydralazine, and isosorbide dinitrate on myocardial hemodynamics in patients with refractory heart failure.
    Biddle TL; Moses HW
    J Clin Pharmacol; 1981; 21(8-9):343-50. PubMed ID: 7276228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Bellin EY
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15761996
    [No Abstract]   [Full Text] [Related]  

  • 53. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
    G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
    [No Abstract]   [Full Text] [Related]  

  • 54. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Moran AE; Cooper RS
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15758018
    [No Abstract]   [Full Text] [Related]  

  • 55. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasodilators for chronic congestive heart failure.
    Med Lett Drugs Ther; 1988 Jan; 30(758):13-4. PubMed ID: 3277025
    [No Abstract]   [Full Text] [Related]  

  • 57. Statistical significance of Veterans Administration Vasodilator Heart Failure Trial results.
    Cohn JN
    Am J Cardiol; 1990 Dec; 66(20):1507-8. PubMed ID: 2252001
    [No Abstract]   [Full Text] [Related]  

  • 58. Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies.
    Haq A; Rakowski H; Baigrie R; McLaughlin P; Burns R; Tihal H; Hilton D; Feiglin D
    Am J Cardiol; 1982 Feb; 49(2):439-44. PubMed ID: 6800252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure.
    Massie B; Kramer B; Haughom F
    Circulation; 1981 Mar; 63(3):658-64. PubMed ID: 6780233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Race and a heart drug.
    Peota C
    Minn Med; 2005 Mar; 88(3):11. PubMed ID: 15852585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.